Correlation Between Delaware Diversified and Franklin Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Delaware Diversified and Franklin Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Delaware Diversified and Franklin Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Delaware Diversified Income and Franklin Biotechnology Discovery, you can compare the effects of market volatilities on Delaware Diversified and Franklin Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Delaware Diversified with a short position of Franklin Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Delaware Diversified and Franklin Biotechnology.

Diversification Opportunities for Delaware Diversified and Franklin Biotechnology

0.05
  Correlation Coefficient

Significant diversification

The 3 months correlation between Delaware and Franklin is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Delaware Diversified Income and Franklin Biotechnology Discove in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Biotechnology and Delaware Diversified is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Delaware Diversified Income are associated (or correlated) with Franklin Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Biotechnology has no effect on the direction of Delaware Diversified i.e., Delaware Diversified and Franklin Biotechnology go up and down completely randomly.

Pair Corralation between Delaware Diversified and Franklin Biotechnology

Assuming the 90 days horizon Delaware Diversified Income is expected to generate 0.24 times more return on investment than Franklin Biotechnology. However, Delaware Diversified Income is 4.18 times less risky than Franklin Biotechnology. It trades about 0.16 of its potential returns per unit of risk. Franklin Biotechnology Discovery is currently generating about 0.03 per unit of risk. If you would invest  745.00  in Delaware Diversified Income on December 23, 2024 and sell it today you would earn a total of  22.00  from holding Delaware Diversified Income or generate 2.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Delaware Diversified Income  vs.  Franklin Biotechnology Discove

 Performance 
       Timeline  
Delaware Diversified 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Delaware Diversified Income are ranked lower than 12 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong technical and fundamental indicators, Delaware Diversified is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Franklin Biotechnology 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Franklin Biotechnology Discovery are ranked lower than 2 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Franklin Biotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Delaware Diversified and Franklin Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Delaware Diversified and Franklin Biotechnology

The main advantage of trading using opposite Delaware Diversified and Franklin Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Delaware Diversified position performs unexpectedly, Franklin Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Biotechnology will offset losses from the drop in Franklin Biotechnology's long position.
The idea behind Delaware Diversified Income and Franklin Biotechnology Discovery pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Equity Valuation
Check real value of public entities based on technical and fundamental data